Selecting raw materials is one of the earliest steps in the development of mRNA vaccines and therapeutics. The materials you choose have the potential...
Content provided by Recipharm AB | 28-Nov-2022
| Case Study
When Arcturus presented its mRNA vaccine candidate to Recipharm, it was at the stage of a frozen product, a ready-to-administer sterile injectable for...
Content provided by Wheeler Bio | 17-Nov-2022
| White Paper
As the Pharma 4.0 initiative sets a new industry paradigm, more biomanufacturing companies are asking how they can design and build facilities that apply...
Content provided by Actylis – The Partner of Choice | 16-Nov-2022
| White Paper
Actylis manufactures buffers, process solutions, cleaning solutions, Water for Injection (WFI) for further processing, and custom liquid blends in compliance...
Content provided by Actylis – The Partner of Choice | 09-Nov-2022
| White Paper
By combining 75+ years of manufacturing and sourcing expertise, Actylis provides a wide portfolio of GMP ingredients to the pharma & biopharma market,...
Content provided by Wheeler Bio | 20-Oct-2022
| White Paper
To solve for the significant bottlenecks often presented by conventional cell line development processes, this article discusses how Wheeler Bio is leveraging...
Content provided by CellCarta | 08-Aug-2022
| Case Study
Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...
Content provided by Thermo Fisher Scientific | 25-Jul-2022
| Case Study
The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...
Content provided by Curia | 16-May-2022
| White Paper
The clinical value of biologics for the treatment of many disease indications has been accompanied by phenomenal sales. By 2026, the global market for...
Content provided by Baxter BioPharma Solutions | 16-Feb-2022
| White Paper
The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...
Process development is a crucial step in viral vector manufacturing and a successful CDMO partnership can help navigate the challenges associated with...
With the current increase in development and investment, gene therapy companies will increasingly be looking to streamline the manufacture and commercialization...
Process development is a crucial step in viral vector manufacturing and a successful CDMO partnership can help navigate the challenges associated with...
Content provided by Roquette Pharma Solutions | 14-Jun-2019
| Case Study
Therapeutic proteins are inherently unstable and sensitive to temperature change, shearing, shaking, solvents, ionic strength, purity, protein concentration,...
Content provided by Marken | 02-Jul-2018
| Case Study
A desperate mother in Germany urged her team of doctors to reach out to a Marken client on behalf of her two year old girl. The child was battling leukemia...
Content provided by Pall Biotech | 15-Jun-2018
| Case Study
Would you like to enhance your downstream process, increase production capacity and reduce costs? This case study application note demonstrates how implementing...
Content provided by UGA Biopharma | 13-Mar-2018
| Research Study
Aflibercept (Zaltrap®) is a recombinant fusion protein with complex post-translational modifications. Therefore deep understanding of biosimilar development...
Content provided by Catalent Pharma Solutions | 06-Mar-2018
| White Paper
Download the eBook written by Catalent experts to learn about innovative products and techniques for scale-up of complex biologics, get optimal cell culture...
Content provided by William Reed | 19-Oct-2017
| Research Study
In September 2017, BioPharma-Reporter.com conducted its second annual ‘state of the industry’ survey on its user base of biopharmaceutical industry professionals....
Content provided by Eppendorf Bioprocess Solutions | 27-Jun-2017
| Infographic
DNA concentration, mastermix preparation, temperature management: Doing PCR like a pro can be more complex than it seems.The Eppendorf infographic helps...
Content provided by Pall Biotech | 01-Jun-2017
| White Paper
For many years cylindrical stainless steel tanks have been used in biopharmaceutical production.The primary reason for the cylindrical shape was that it...
With the rising interest in biopharmaceuticals, drug developers need to quickly understand and evaluate the binding of therapeutic antibodies to Fc receptors. ...
Content provided by Baxter BioPharma Solutions | 13-Feb-2017
| White Paper
The ultimate goal of formulation development is a stable product. In the case of a protein product, that can be defined as delivering the correct dose,...
Content provided by Catalent | 07-Nov-2016
| Infographic
With the increasing complexity of biologics and growing competition with players ranging from small start-ups to large pharma, an aggressive development...
Content provided by Pall Biotech | 25-Jul-2016
| White Paper
Learn the advantages of transferring from single column to continuous chromatography processes with connected unit operations. This poster titled “Demonstration...
Content provided by William Reed | 14-Jun-2016
| Insight Guide
In May 2016, BioPharma-Reporter conducted its inaugural ‘state of the industry’ survey. The key objective of the poll was to gauge views about the current...
Content provided by Catalent Pharma Solutions | 30-Nov-2015
| White Paper
The advanced aseptic processing of ADVASEPT® technology can reduce the risk associated with aseptic filling of biologics and drastically reduce the potential...
Content provided by Eppendorf Bioprocess Solutions | 09-Nov-2015
| Infographic
Reverse pipetting, problem liquids, getting the angle right: Pipetting like a pro can be more complex than it seems. The Eppendorf infographic helps you...
Content provided by Applikon Biotechnology | 12-Oct-2015
| Case Study
Screening of large number of cell lines, specific media or target drug could be tedious and expensive work. This is also the case for the characterization...
Content provided by World Courier | 23-Jun-2015
| Infographic
Download World Courier’s latest piece which shares the story of the changes in temperature-controlled transport and what these trends mean to your business....
Content provided by AdvantaPure® | 22-Jun-2015
| White Paper
Pharmaceutical fluid transfer involves many tubing-to-fitting connections, and unfortunately those connections can leak and result in contamination, production...
Content provided by SGS Life Science Services | 25-May-2015
| Case Study
The aggregation of biopharmaceuticals is a complex process, for efficient analysis it’s essential to carefully select orthogonal methods to minimize gaps...
Content provided by Applikon Biotechnology | 09-Apr-2015
| White Paper
The Applikon BioSep system is a unique, cell retention device for high-density perfusion processes. BioSep is the ultimate tool for cell culture perfusion...
Content provided by Catalent | 09-Feb-2015
| White Paper
Assessment of biosimilar molecules requires an orthogonal analytical approach. Any one particular analytical technique is not able to fully define the...
